Mondi, Mary Joy S.

HRN: 21-84-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2022
CEFTRIAXONE 1G (VIAL)
08/28/2022
09/03/2022
IV
2g
OD
Infectious Diarrhea, UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: